Literature DB >> 12956939

P-glycoprotein restricted transport of nimodipine across blood-brain barrier.

Li Zhang1, Xiao-Dong Liu, Lin Xie, Guang-Ji Wang.   

Abstract

AIM: To examine whether the transport of nimodipine (NMD) from the circulating blood into the brain is restricted by P-glycoprotein (P-gp) in rat brain capillary endothelial cells (BCEC).
METHODS: When cells reached confluence, a time course of NMD uptake was recorded by incubation with a medium containing NMD 10 mg/L at 37 degrees C. Effects of various agents in the steady-state uptake of NMD were tested by co-administration with NMD and each compound to cells at 37 degrees C for 90 min. The uptake of NMD was measured for 90 min. Effects of P-gp inhibitors on the efflux of NMD from primary cultured BCEC were studied by administration of erythromycin, clarithromycin, cyclosporin A (CsA), and Hanks' solution after the accumulation of NMD by BCEC at 37 degrees C for 90 min.
RESULTS: The uptake of NMD by primary cultured rat BCEC was time-dependent, and the steady-state uptake of NMD was increased in the presence of several substrates of P-gp in BCEC. The steady-state uptake was also significantly increased (P<0.01) when cellular ATP was depleted by treatment with sodium azide. Furthermore, efflux of NMD from BCEC was inhibited by erythromycin,clarithromycin, and CsA.
CONCLUSION: The permeability of NMD into the brain is restricted by P-gp and increased by co-administration with P-gp inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956939

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Correlation between quinolone uptakes by BCECs in vitro and brain-to-plasma concentration ratios in rats.

Authors:  X D Liu; D W Wang; L Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

2.  Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort.

Authors:  Ying Zhao; Desheng Zhai; Hui He; Tingting Li; Xijing Chen; Hui Ji
Journal:  Eur J Clin Pharmacol       Date:  2009-02-11       Impact factor: 2.953

3.  Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.

Authors:  Chun Wu; Qiongfeng Liao; Meicun Yao; Xinjun Xu; Yuting Zhou; Xueying Hou; Zhiyong Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-15       Impact factor: 2.441

4.  Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats.

Authors:  X D Liu; X L Wang; L Xie; G J Wang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

5.  Verapamil exerts biphasic modulation on phenobarbital transport across the blood-brain barrier: evidence from an in vivo and in vitro study.

Authors:  Dan Yao; Zhi-Hong Yang; Li Liu; Jia Li; Yun-Li Yu; Lu-Lu Zhang; Xian Pan; Xiao-Dong Liu; Lin Xie; Guang-Ji Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-19       Impact factor: 3.000

6.  Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats.

Authors:  X D Liu; L Zhang; L Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Oct-Dec       Impact factor: 2.441

7.  The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord.

Authors:  Jennifer N Dulin; Meredith L Moore; Raymond J Grill
Journal:  J Neurotrauma       Date:  2013-01-23       Impact factor: 5.269

8.  Nimodipine-Loaded Pluronic® Block Copolymer Micelles: Preparation, Characterization, In-vitro and In-vivo Studies.

Authors:  Farzaneh Sotoudegan; Mohsen Amini; Mehrdad Faizi; Reza Aboofazeli
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.